Staff Changes, New Leadership May Disrupt FDA Under Trump

Donald Trump’s victory in the US presidential election once again is creating a potentially unsettling transition process for the FDA. While it is far from clear that the new administration actually will want to disrupt the agency, there are several ways it could happen.

Red Lightbulb Shattering
(Gualtiero Boffi/Shutterstock)

More from Medtech Insight

More from Legislation